c-Jun N-TERMINAL KINASE BINDING DOMAIN-DEPENDENT PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 AND MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 AND BALANCING CROSS-TALK BETWEEN c-Jun N-TERMINAL KINASE AND EXTRACELLULAR SIGNAL-REGULATED KINASE PATHWAYS IN CORTICAL NEURONS

被引:37
作者
Repici, M. [2 ]
Mare, L. [2 ]
Colombo, A. [1 ]
Ploia, C. [1 ]
Sclip, A. [1 ]
Bonny, C. [3 ]
Nicod, P. [3 ]
Salmona, M. [1 ]
Borsello, T. [1 ,2 ]
机构
[1] Ist Ric Farmacol Mario Negri, Biol Neurodeg Disorders Lab, Neuronal Death & Neuroprotect Unit, I-20156 Milan, Italy
[2] Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland
[3] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
JNK; MKK4; MKK7; ERK; MEK1; D-JNKI1; PEPTIDE INHIBITOR; CELL-DEATH; DOCKING SITES; NH2-TERMINAL KINASE; CEREBRAL-ISCHEMIA; DOWN-REGULATION; HEARING-LOSS; JNK; TRANSDUCTION; INJURY;
D O I
10.1016/j.neuroscience.2008.11.049
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The c-Jun N-terminal kinase (JNK) is a mitogen-activated protein kinase (MAPK) activated by stress-signals and involved in many different diseases. Previous results proved the powerful effect of the cell permeable peptide inhibitor D-JNKI1 (D-retro-inverso form of c-Jun N-terminal kinase-inhibitor) against neuronal death in CNS diseases, but the precise features of this neuroprotection remain unclear. We here performed cell-free and in vitro experiments for a deeper characterization of D-JNKI1 features in physiological conditions. This peptide works by preventing JNK interaction with its c-Jun N-terminal kinase-binding domain (JBD) dependent targets. We here focused on the two JNK upstream MAPKKs, mitogen-activated protein kinase kinase 4 (MKK4) and mitogen-activated protein kinase kinase 7 (MKK7), because they contain a JBD homology domain. We proved that D-JNKI1 prevents MKK4 and MKK7 activity in cell-free and in vitro experiments: these MAPKK could be considered not only activators but also substrates of JNK. This means that D-JNKI1 can interrupt downstream but also upstream events along the JNK cascade, highlighting a new remarkable feature of this peptide. We also showed the lack of any direct effect of the peptide on p38, MEK1, and extracellular signal-regulated kinase (ERK) in cell free, while in rat primary cortical neurons JNK inhibition activates the MEK1-ERK-Ets1/c-Fos cascade. JNK inhibition induces a compensatory effect and leads to ERK activation via MEK1, resulting in an activation of the survival pathway(MEK1/ERK) as a consequence of the death pathway-(JNK) inhibition. This study should hold as an important step to clarify the strong neuroprotective effect of D-JNKI1. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:94 / 103
页数:10
相关论文
共 50 条
  • [41] c-Jun N-terminal kinase regulates CTP: phosphocholine cytidylyltransferase
    Ryan, AJ
    Andrews, M
    Zhou, JM
    Mallampalli, RK
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2006, 447 (01) : 23 - 33
  • [42] Recent Advances in c-Jun N-Terminal Kinase (JNK) Inhibitors
    Li, Gang
    Qi, Wenqing
    Li, Xiaoxun
    Zhao, Jinwu
    Luo, Meihua
    Chen, Jianjun
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (03) : 607 - 627
  • [43] c-Jun N-Terminal kinase signaling inhibitors under development
    Han S.-Y.
    Toxicological Research, 2008, 24 (2) : 93 - 100
  • [44] MEASURING THE CONSTITUTIVE ACTIVATION OF C-JUN N-TERMINAL KINASE ISOFORMS
    Nitta, Ryan T.
    Badal, Shawn S.
    Wong, Albert J.
    METHODS IN ENZYMOLOGY, VOLUME 484: CONSTITUTIVE ACTIVITY IN RECEPTORS AND OTHER PROTEINS, PART A, 2010, 484 : 531 - 548
  • [45] Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development
    Wang, Juan
    Tai, Guixiang
    TARGETED ONCOLOGY, 2016, 11 (06) : 723 - 738
  • [46] Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity
    Du, Kuo
    Xie, Yuchao
    McGill, Mitchell R.
    Jaeschke, Hartmut
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (11) : 1769 - 1779
  • [47] Involvement of c-jun N-terminal kinase and p38 mitogen-activated protein kinase in α1B-adrenergic receptor/Gαq-induced inhibition of cell proliferation
    Yamauchi, J
    Itoh, H
    Shinoura, H
    Miyamoto, Y
    Hirasawa, A
    Kaziro, Y
    Tsujimoto, G
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (04) : 1019 - 1023
  • [48] Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injury
    Hui Su Lee
    Hee Jae Kim
    Chang Sook Moon
    Young Hae Chong
    Jihee Lee Kang
    Respiratory Research, 5
  • [49] MIP-1α induces inflammatory responses by upregulating chemokine receptor 1/chemokine receptor 5 and activating c-Jun N-terminal kinase and mitogen-activated protein kinase signaling pathways in acute pancreatitis
    Wu, Xingmao
    Ji, Kaiqiang
    Wang, Haiyuan
    Zhao, Yang
    Jia, Jia
    Gao, Xiaopeng
    Zang, Bin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 2994 - 3000
  • [50] Type 2 cGMP-dependent protein kinase regulates homeostasis by blocking c-Jun N-terminal kinase in the colon epithelium
    R Wang
    I-K Kwon
    N Singh
    B Islam
    K Liu
    S Sridhar
    F Hofmann
    D D Browning
    Cell Death & Differentiation, 2014, 21 : 427 - 437